India is so big, we can’t ignore it, we always keep it on our radar: Severin Schwan, Roche CEOSchwan says India’s healthcare spend relative to GDP is very low, compared to economies such as China which spends about 5% to 6% of its GD...
Are India’s life sciences startups turning a corner?A life sciences or medical product company is yet to make it big anywhere in India, despite a startup culture that is 15 years old.
India's drug discovery and development: Small research firms aim to change face of cancer therapyIndia is not known for developing drugs, let along cancer drugs, but a few small and niche firms are trying exactly that, reports ET.
Major pharma-deals: How anti-cancer drugs are reshaping the pharmaceutical industryNew and considerable optimism over cancer drugs will drive deal-making in pharma over the decade, with companies weak in this segment tryin...